SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity

The current coronavirus disease 2019 (COVID-19) pandemic that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a significant threat to public health. Although vaccines based on the mRNA of the SARS-CoV-2 spike protein have been developed to induce both cellular and h...

Descripción completa

Detalles Bibliográficos
Autores principales: Yajima, Yuki, Kosaka, Akemi, Ohkuri, Takayuki, Hirohashi, Yoshihiko, Li, Dongliang, Nagasaki, Takeshi, Nagato, Toshihiro, Torigoe, Toshihiko, Kobayashi, Hiroya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559948/
https://www.ncbi.nlm.nih.gov/pubmed/37809871
http://dx.doi.org/10.1016/j.heliyon.2023.e20192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559948/
https://www.ncbi.nlm.nih.gov/pubmed/37809871
http://dx.doi.org/10.1016/j.heliyon.2023.e20192

Ejemplares similares